Views & Analysis | Perspectives on pharma industry issues

Oncology

Radiopharmaceutical development is accelerating. Preclinical...

Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development.

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Patients

Brain puzzle with piece missing, letting through the sunlight

Exploring mixed episodes in bipolar I disorder: When mania a...

One of the most misunderstood and often overlooked aspects of BD-I is the occurrence of mixed episodes.

R&D

Redefining drug discovery: Morocco’s biotech strategy for in...

Ongoing work in Morocco demonstrates how developing research infrastructure can support innovative approaches grounded in locally generated data.

Sales & Marketing

Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

AI in the medical devices sector: Fostering innovation while...

Among all the changes happening in the healthcare landscape in the last few years, the advent of digital health technology stands out as one poised to fuel innovation and revolutionise heal

Market Access

Changing Faces May-June 2024: Government, non-profit, and pr...

Our fourth Changing Faces round-up is one that we don’t always publish, but in May and June we heard about enough hires in the public sector, non-profit, and academic worlds to stand in the

Patients

pharmaphorum podcast Episode 147a featuring Farrell Simon

Chronic cough and the patient voice

Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives.

Sales & Marketing

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Sales & Marketing

Commercial teams are running yesterday's plays. AI just chan...

What leading companies are building now is fundamentally different: decision systems.

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Digital

lady pointing at a number of data points

Solution Spotlight: Medscape AI

Medscape AI introduces a global, medical-grade AI search tool exclusively curated from the world’s largest body of clinically vetted content.

Market Access

Interview with Marjorie Sidhoum at BIO Europe 2026

BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...

Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.

Market Access

A panel on direct-to-patient at Reuters Pharma USA

In DTC's watershed moment, trust and partnership are key

More and more pharma companies are turning to direct-to-patient access models. But the consensus at Reuters Pharma USA is that they can't do it alone.